CVS Health Corporation
NYSE:CVS
Sector
Location
Market Cap
USD 75.45 B
Share Price
USD 59.64
Avg Daily Volume
9,310,473
Change (1 day)
-1.75%
Change (1 year)
-2.23%
Change (YTD)
32.86%
CVS Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 6.98%
CVS Health Corporation Return on Equity (ROE) is 6.98% for the Trailing 12 Months (TTM) ending March 31, 2025, a -29.04% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
CVS Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 9.84%, a 74.96% change year over year.
-
CVS Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 5.63%, a -48.14% change year over year.
-
CVS Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 10.85%, a 1.62% change year over year.
-
CVS Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 10.68%, a -6.51% change year over year.
StockViz
Competitors
UnitedHealth Group Incorporated
USD 282.12
UNH
+1.06
0.38%
Merck & Co., Inc.
USD 84.06
MRK
-0.65
-0.77%
McKesson Corporation
USD 706.28
MCK
-5.54
-0.78%
Elevance Health Inc.
USD 285.98
ELV
-3.12
-1.08%
Cencora, Inc.
USD 286.20
COR
-4.16
-1.43%
Cardinal Health, Inc.
USD 156.33
CAH
-0.81
-0.52%
BeOne Medicines Ltd.
USD 294.51
ONC
+3.04
1.04%
Humana Inc.
USD 231.52
HUM
-6.46
-2.71%
JD Health International Inc.
USD 6.24
6618.HK
+0.04
0.65%
Fresenius Medical Care AG & Co. KGaA
USD 51.85
FME.DE
-0.99
-1.88%
Demant A/S
USD 43.12
DEMANT.CO
-0.78
-1.77%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.46
2196.HK
+0.04
1.61%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.63
2607.HK
+0.01
0.50%
Sinopharm Group Co. Ltd.
USD 2.47
1099.HK
-0.04
-1.49%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.31
002653.SZ
-0.07
-1.01%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
UnitedHealth Group Incorporated
USD 282.12
UNH
+1.06
0.38%
Merck & Co., Inc.
USD 84.06
MRK
-0.65
-0.77%
McKesson Corporation
USD 706.28
MCK
-5.54
-0.78%
Elevance Health Inc.
USD 285.98
ELV
-3.12
-1.08%
Cencora, Inc.
USD 286.20
COR
-4.16
-1.43%
Cardinal Health, Inc.
USD 156.33
CAH
-0.81
-0.52%
BeOne Medicines Ltd.
USD 294.51
ONC
+3.04
1.04%
Humana Inc.
USD 231.52
HUM
-6.46
-2.71%
JD Health International Inc.
USD 6.24
6618.HK
+0.04
0.65%
Fresenius Medical Care AG & Co. KGaA
USD 51.85
FME.DE
-0.99
-1.88%
Demant A/S
USD 43.12
DEMANT.CO
-0.78
-1.77%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.46
2196.HK
+0.04
1.61%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.63
2607.HK
+0.01
0.50%
Sinopharm Group Co. Ltd.
USD 2.47
1099.HK
-0.04
-1.49%
Haisco Pharmaceutical Group Co., Ltd.
USD 7.31
002653.SZ
-0.07
-1.01%